…
ADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. It also provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. In addition, the company offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Further, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as engages in contract manufacturing. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Adm Tronics Unlimited (OTCQB: ADMT) is sparse, with limited recent disclosures about its operations or financials, so its core business and long-term growth drivers are not clearly documented. Investors seeking exposure to microcap turnaround or development-stage opportunities may find upside if the company delivers clearer reporting or successful operational progress.
Key risks include opaque financial reporting, low liquidity and thin trading, potential need for additional financing, and typical small-cap execution and governance risks.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | -0.12M | -0.88M | 0.02M | -0.45M | -0.67M |
| Net income | -0.12M | -0.88M | -0.10M | -1.38M | -0.60M |
| Selling general administrative | 0.97M | 1.36M | 1.09M | 1.67M | 1.07M |
| Gross profit | 1.40M | 1.12M | 1.66M | 1.25M | 1.16M |
| Reconciled depreciation | 0.09M | 0.09M | 0.04M | 0.11M | 0.15M |
| Ebit | - | - | - | -1.13M | -0.66M |
| Ebitda | - | - | 0.08M | -0.33M | -0.51M |
| Non operating income net other | - | - | - | - | 0.02M |
| Operating income | -0.09M | -0.82M | 0.03M | -1.13M | -0.68M |
| Other operating expenses | - | - | - | - | 2.97M |
| Interest expense | 0.04M | 0.03M | 0.02M | 0.02M | 0.01M |
| Tax provision | 0.00M | 0.00M | 0.12M | 0.94M | -0.07M |
| Interest income | 0.01M | 0.03M | 0.01M | 0.00M | 0.01M |
| Net interest income | -0.03M | -0.00M | -0.01M | -0.01M | 0.00M |
| Income tax expense | - | - | - | 0.94M | -0.07M |
| Total revenue | 3.20M | 2.97M | 3.68M | 3.21M | 3.09M |
| Total operating expenses | 3.29M | 3.79M | 3.65M | 4.34M | 1.84M |
| Cost of revenue | 1.80M | 1.85M | 2.02M | 1.96M | 1.93M |
| Total other income expense net | -0.00M | -0.05M | - | 0.69M | - |
| Net income from continuing ops | -0.12M | -0.88M | -0.10M | -1.38M | -0.60M |
| Net income applicable to common shares | - | - | - | -1.38M | -0.60M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 2.13M | 2.14M | 3.09M | 3.25M | 5.21M |
| Intangible assets | 0.02M | 0.02M | 0.01M | 0.02M | 0.02M |
| Other current assets | 0.00M | 0.02M | 0.04M | - | 0.05M |
| Total liab | 1.46M | 1.45M | 1.52M | 1.88M | 2.46M |
| Total stockholder equity | 0.67M | 0.69M | 1.57M | 1.37M | 2.76M |
| Other current liab | - | - | 0.36M | 0.45M | 0.37M |
| Common stock | - | - | - | 0.03M | 0.03M |
| Capital stock | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M |
| Retained earnings | -32.97M | -32.95M | -32.07M | -31.97M | -30.59M |
| Other assets | - | - | - | 0.61M | 1.53M |
| Cash | 0.38M | 0.54M | 1.00M | 1.04M | 1.55M |
| Total current liabilities | 1.15M | 1.12M | 1.11M | 1.47M | 1.46M |
| Net debt | 0.14M | - | - | - | - |
| Short term debt | - | - | - | - | 0.51M |
| Short long term debt | 0.53M | 0.51M | 0.26M | 0.34M | 0.51M |
| Property plant equipment | - | - | - | 0.51M | 0.23M |
| Total current assets | 1.25M | 1.21M | 1.99M | 2.21M | 2.97M |
| Long term investments | 0.23M | - | - | - | 0.22M |
| Net tangible assets | - | - | - | 1.36M | 2.74M |
| Net receivables | 0.53M | 0.34M | 0.50M | 0.73M | 1.15M |
| Long term debt | - | - | - | 0.01M | 0.43M |
| Inventory | 0.34M | 0.31M | 0.44M | 0.29M | 0.23M |
| Accounts payable | 0.30M | 0.27M | 0.32M | 0.33M | 0.58M |
| Common stock total equity | - | - | - | - | 0.03M |
| Retained earnings total equity | - | - | - | - | -30.59M |
| Non currrent assets other | 0.24M | 0.41M | 0.32M | 0.27M | 1.77M |
| Non current assets total | 0.88M | 0.92M | 1.10M | 1.14M | 2.24M |
| Capital lease obligations | 0.32M | 0.41M | 0.49M | 0.57M | 0.64M |
| Long term debt total | - | - | - | - | 0.43M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -0.23M | 0.00M | - | - | 0.00M |
| Change to liabilities | - | - | - | -0.06M | -0.01M |
| Net borrowings | -0.02M | 0.28M | - | 0.07M | 0.90M |
| Total cash from financing activities | 0.06M | 0.26M | -0.26M | 0.07M | 0.88M |
| Change to operating activities | - | - | - | -0.01M | -0.13M |
| Net income | -0.12M | -0.88M | -0.10M | -1.38M | -0.60M |
| Change in cash | -0.15M | -0.47M | -0.13M | -0.41M | 0.11M |
| Begin period cash flow | 0.54M | 1.00M | 1.14M | 1.55M | 1.44M |
| End period cash flow | 0.38M | 0.54M | 1.00M | 1.04M | 1.55M |
| Total cash from operating activities | 0.01M | -0.71M | 0.13M | -0.48M | -0.77M |
| Depreciation | 0.09M | 0.09M | 0.04M | 0.11M | 0.15M |
| Change to inventory | -0.13M | 0.10M | -0.31M | -0.07M | -0.06M |
| Change to account receivables | -0.18M | 0.08M | 0.23M | -0.19M | -0.26M |
| Other cashflows from financing activities | - | - | - | - | -0.02M |
| Change to netincome | - | - | - | 1.13M | 0.19M |
| Capital expenditures | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M |
| Change receivables | - | - | - | - | -0.26M |
| Cash flows other operating | - | - | - | - | -0.19M |
| Cash and cash equivalents changes | - | - | - | - | 0.11M |
| Change in working capital | -0.06M | -0.20M | -0.06M | -0.33M | -0.41M |
| Stock based compensation | 0.00M | 0.00M | 0.07M | 0.00M | 0.02M |
| Other non cash items | -0.09M | -0.01M | -0.08M | -0.77M | -0.07M |
| Free cash flow | 0.01M | -0.72M | 0.13M | -0.57M | -0.77M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ADMT Adm Tronics Unltd |
-0.03 19.59% |
0.11 | - | - | 1.31 | 7.40 | 1.78 | 47.13 |
| ABT Abbott Laboratories |
-0.51 0.46% |
109.95 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
-0.56 0.55% |
101.03 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-5.93 1.83% |
318.36 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
0.30 0.63% |
48.57 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
ADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. It also provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. In addition, the company offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Further, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as engages in contract manufacturing. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.
| Name | Title | Year Born |
|---|---|---|
| Dr. Andre' DiMino | Pres, CEO, CFO & Director | 1957 |
| Mr. Rafael Santiago | Head of Investor Relations Unit | NA |
| Dr. Andre' DiMino | President, CEO, CFO & Director | 1957 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.